A detailed history of Federated Hermes, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 330,493 shares of COLL stock, worth $9.63 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
330,493
Previous 329,466 0.31%
Holding current value
$9.63 Million
Previous $10.6 Million 20.38%
% of portfolio
0.03%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$31.4 - $39.07 $32,247 - $40,124
1,027 Added 0.31%
330,493 $12.8 Million
Q2 2024

Aug 08, 2024

SELL
$31.36 - $39.99 $2,038 - $2,599
-65 Reduced 0.02%
329,466 $10.6 Million
Q1 2024

May 14, 2024

BUY
$31.23 - $40.91 $3.65 Million - $4.78 Million
116,763 Added 54.88%
329,531 $12.8 Million
Q4 2023

Jan 31, 2024

BUY
$21.16 - $30.8 $1.94 Million - $2.83 Million
91,911 Added 76.05%
212,768 $6.55 Million
Q3 2023

Nov 13, 2023

BUY
$21.23 - $24.28 $391,990 - $448,305
18,464 Added 18.03%
120,857 $2.7 Million
Q2 2023

Aug 14, 2023

BUY
$21.06 - $24.0 $615,436 - $701,352
29,223 Added 39.94%
102,393 $2.2 Million
Q1 2023

May 08, 2023

BUY
$23.0 - $29.88 $1.68 Million - $2.19 Million
73,170 New
73,170 $1.76 Million
Q2 2022

Aug 15, 2022

SELL
$14.22 - $20.88 $3.73 Million - $5.47 Million
-262,095 Reduced 100.0%
9 $1,000
Q1 2022

May 13, 2022

SELL
$17.2 - $22.5 $3,990 - $5,220
-232 Reduced 0.09%
262,104 $5.34 Million
Q4 2021

Feb 14, 2022

BUY
$17.5 - $21.35 $1.22 Million - $1.49 Million
69,781 Added 36.24%
262,336 $4.9 Million
Q3 2021

Nov 15, 2021

BUY
$17.75 - $25.39 $371,880 - $531,945
20,951 Added 12.21%
192,555 $3.8 Million
Q2 2021

Aug 16, 2021

BUY
$21.74 - $25.28 $3.73 Million - $4.33 Million
171,379 Added 76168.44%
171,604 $4.06 Million
Q1 2021

May 13, 2021

SELL
$19.25 - $26.1 $73,650 - $99,858
-3,826 Reduced 94.45%
225 $5,000
Q4 2020

Feb 12, 2021

SELL
$17.83 - $22.29 $555,119 - $693,976
-31,134 Reduced 88.49%
4,051 $81,000
Q3 2020

Nov 12, 2020

SELL
$15.78 - $20.82 $1.47 Million - $1.94 Million
-93,017 Reduced 72.56%
35,185 $733,000
Q2 2020

Aug 13, 2020

SELL
$15.49 - $23.51 $2.02 Million - $3.06 Million
-130,270 Reduced 50.4%
128,202 $2.24 Million
Q1 2020

May 13, 2020

BUY
$13.89 - $25.45 $1.32 Million - $2.42 Million
95,210 Added 58.32%
258,472 $4.22 Million
Q4 2019

Feb 14, 2020

BUY
$10.7 - $22.24 $894,220 - $1.86 Million
83,572 Added 104.87%
163,262 $3.36 Million
Q3 2019

Nov 14, 2019

BUY
$10.16 - $13.28 $673,760 - $880,663
66,315 Added 495.81%
79,690 $915,000
Q2 2019

Aug 14, 2019

BUY
$10.62 - $16.59 $140,024 - $218,739
13,185 Added 6939.47%
13,375 $176,000
Q3 2018

Nov 13, 2018

SELL
$14.16 - $24.3 $424 - $729
-30 Reduced 13.64%
190 $3,000
Q2 2018

Aug 10, 2018

SELL
$21.79 - $28.29 $8,955 - $11,627
-411 Reduced 65.13%
220 $5,000
Q1 2018

May 09, 2018

SELL
$18.15 - $29.21 $2,323 - $3,738
-128 Reduced 16.86%
631 $16,000
Q4 2017

Feb 14, 2018

BUY
$9.3 - $19.14 $7,058 - $14,527
759
759 $0

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $995M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.